CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
Nasalferon in COVID-19	12/11/2021	Registered
CIGB 2020 in contacts and SARS-CoV-2 infection suspects	13/04/2020	Registered outdated
COURAGE-2 Study	14/03/2019	Registered outdated
ESPERANZA study	14/04/2020	Registered outdated
CIGB-258 at COVID-19	14/05/2020	Registered outdated
Safety and immunogenicity of the CIGB 2020.	14/07/2020	Registered outdated
Jusvinza in Severe Patients with Acquired Community Pneumonia	14/10/2022	Registered
Study in Hematological Malignancies	14/11/2014	Registered
Phase I with CIGB-814 in rheumatoid arthritis patients	16/02/2017	Registered
CENTAURO-6 Study	16/02/2017	Registered
ABDALA Clinical Study - Phase III	18/03/2021	Registered
Jusvinza in rheumatoid arthritis	20/04/2022	Registered
THERESA	2008-10-07	Registered
FarmaPEG-I	2008-10-07	Registered
FASECU I	2008-10-16	Registered
Recombinant interferon alpha-2b in paranoid schizophrenia.	2009-02-11	Registered
Recombinant IFN alpha-2b for relapsing –remitting multiple sclerosis.	2009-02-11	Registered
Phase II clinical trial for the evaluation of the therapeutic vaccine candidate Terap C.	2009-02-11	Registered
CITOPROT-III	2009-02-26	Registered
Safety and immunogenicity of commercial Hepatitis B vaccines.	2009-02-27	Registered